| Englischer Name | Forschungscode | Forschungsphase | Firma | Indikationen | Klinische Studie |
|---|---|---|---|---|---|
| TEV-56192 | TEV-56192 | Phase 1 Clinical | Teva Pharmaceutical Industries Ltd | Nervous System Diseases | Details |
| OA-235i | OA-235i | Phase 1 Clinical | Oasis Pharmaceuticals LLC | Metabolic Dysfunction-Associated Steatotic Liver Disease | Details |
| MEDI-0618 | MEDI-0618 | Phase 1 Clinical | Astrazeneca Plc | Chronic Pain | Details |